SuperworthAbCellera Biologics shares outstanding ABCL
Diluted shares outstanding, averaged over each quarter, from 2020.
- Latest quarter, to Jun 30, 2026
- 305.6M
- On a year earlier
- +2.4%
- more shares
AbCellera Biologics had 305.6M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 2.4% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 299.7M | +1% |
| FY2024 | 295.5M | +2% |
| FY2023 | 290.4M | +1% |
| FY2022 | 286.3M | −6% |
| FY2021 | 303.4M | −10% |
| FY2020 | 338.8M | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 305.6M | +2% | |
| Q1 FY26 | 303.1M | +2% | |
| Q4 FY25 | 299.7M | +1% | |
| Q3 FY25 | 298.9M | +1% | |
| Q2 FY25 | 298.5M | +1% | |
| Q1 FY25 | 297.7M | +2% | |
| Q4 FY24 | 295.5M | +2% | |
| Q3 FY24 | 294.9M | +2% | |
| Q2 FY24 | 294.2M | +2% | |
| Q1 FY24 | 292.7M | +2% | |
| Q4 FY23 | 290.4M | +1% | |
| Q3 FY23 | 289.5M | −8% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on AbCellera Biologics
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.